• 

  Vaccine to curb Covid spread should now be top priority, says UK scientist

  Health | May 08, 2022 23:10 IST

  COVID19: Scientist says that instead of trying to make a vaccine each time a new variant emerges, it is best to develop something that can curb the spread and not harm people.

• 

  SII's Covid vaccine Covovax now available for children in India: Adar Poonawalla

  India | May 03, 2022 17:13 IST

  Serum Institute of India (SII) Director for Government and Regulatory Affairs Prakash Kumar Singh had written to the Union Health Ministry recently, requesting for Covovax's inclusion in the immunisation drive for children aged 12 to 17 years.

• 

  Instead of Covid vaccine, man gets anti-rabies jab; doctor says would serve as 'precautionary dose'

  India | May 02, 2022 12:23 IST

  Chief Medical Officer of Lakhimpur Kheri Dr Shailendra Bhatnagar said the dose Shivam Jaiswal received would serve as a "precautionary dose against rabies".

• 

  COVID: India's vaccination coverage exceeds 187.67 crore

  India | April 24, 2022 14:26 IST

  India's Active Caseload currently stands at 15,873 and the active cases now constitute 0.04 per cent of the country's total positive cases.

• 

  4th Covid vaccine dose effective in protecting people over 60: Study

  Health | April 16, 2022 20:40 IST

  The study found that a fourth dose can reduce the possibilities of symptomatic infection, hospitalisation, serious illness and mortality among the elders.

• 

  COVID precautionary dose for 18+ available at private vaccination centres from today. Details

  India | April 10, 2022 9:56 IST

  After the announcement, vaccine maker Serum Institute of India (SII) said the precaution dose of its Covishield vaccine will be priced at Rs 600 per shot for eligible individuals.

• 

  Serum Institute's Covishield precaution dose priced at Rs 600 per shot

  India | April 08, 2022 19:23 IST

  SII CEO Adar Poonawalla also welcomed the government’s move to allow precaution dose of the vaccine to all aged above 18 years at private vaccination centres, saying it will further provide long-term protection against the virus, and aid ease of travel.

• 

  Govt panel recommends Serum Institute's Covovax vaccine for 12-17 year olds

  India | April 03, 2022 21:20 IST

  India's drug regulator had approved Covovax for restricted use in emergency situations in adults on December 28 and in the 12-17 age group, subject to certain conditions, on March 9.

• 

  Pfizer Covid vaccine in kids aged 5-11 cut Omicron hospitalisations by 68 per cent

  Health | April 01, 2022 22:52 IST

  "This evidence shows that vaccination reduces this risk substantially in 5 to 11-year-olds. And while vaccination provided adolescents with lower protection against hospitalisation with Omicron versus Delta, it prevented critical illness from both variants," the researcher said.

• 

  Govt may allow administering Covid vaccine booster shots to those travelling abroad for work, study

  India | March 26, 2022 16:28 IST

  With scheduled international flights set to resume from Sunday, the Ministry of External Affairs recently highlighted the travel restrictions being enforced by certain countries in view of the requirement of a third/booster dose.

• 

  Novovax's Covid vaccine gets emergency use authorization for adolescents aged 12-18 yrs in India

  India | March 23, 2022 8:03 IST

  Notably, DCGI initially granted emergency use authorization for Covovax for adults of 18 years old and above in December. In addition, Covovax has also received Emergency Use Listing (EUL) from the WHO.

Advertisement
• 

  What is the gap between 1st, 2nd COVID-19 vaccine & booster shots in India & around the world?

  Health | March 22, 2022 14:08 IST

  Health experts recommend that for better effectiveness of the vaccines people should not only get the complete dosage but also keep in mind the recommended gap duration between each dose. Know more about it here.  

• 

  Phase 2,3 trial data of India's first mRNA COVID vaccine submitted to DCGI

  India | March 18, 2022 22:50 IST

  The company has also developed an Omicron-specific vaccine which will be tested on humans for efficacy and immunogenicity.

• 

  Covid vax prevents infection, severe disease in kidney dialysis patients

  Health | March 10, 2022 16:13 IST

  It is now recommended that all adults and teenagers, especially those who are immunocompromised, receive a third dose of Covid vaccine to ensure an optimal immune response.

• 

  SII seeks permission for phase-3 study of Covid vaccine Covovax as booster dose in adults

  India | February 27, 2022 19:22 IST

  Prakash Kumar Singh, Director, Government and Regulatory Affairs at SII had last week submitted an application to DCGI seeking nod for phase-3, observer-blind, randomised, controlled study to evaluate the safety and immunogenicity of Covovax as booster dose.

• 

  Covid 19: Biological E's Corbevax vaccine gets emergency use approval for 12 to 18 age group

  India | February 21, 2022 18:59 IST

  Corbevax is India's first indigenously developed Receptor Binding Domain (RBD) Protein sub-unit vaccine against COVID-19.

• 

  Canada’s truckers' protests settle down, but could echo in politics

  World | February 21, 2022 9:38 IST

  The protest, which was first aimed at a COVID-19 vaccine mandate for cross-border truckers but also encompassed fury over the range of COVID-19 restrictions and hatred of Prime Minister Justin Trudeau, reflected the spread of disinformation in Canada and simmering populist and right-wing anger.

• 

  DCGI recommends granting EUA to Covid vaccine Corbevax, to be used for 12 to 18 age group

  India | February 14, 2022 23:40 IST

  Corbevax is India's first indigenously developed RBD protein subunit vaccine. However, the government has still not taken a decision on vaccinating those aged below 15 years.

• 

  Here's what Govt said about Covid-19 vaccines for children aged 5 to 15

  India | February 12, 2022 15:57 IST

  Union Health Minister Mansukh Mandaviya said the group of experts has so far not made any recommendation on the vaccination of this category.

• 

  Study reveals COVID19 vaccine hesitancy linked to childhood trauma

  Health | February 03, 2022 9:36 IST

  Based on all their findings, the researchers estimated the likely rates of vaccine hesitancy according to childhood trauma and age: these ranged from around 3.5 per cent among those aged 70 and above with no experience of childhood adversity, to 38 per cent among 18-29 year olds who had experienced 4 or more types of childhood trauma.